Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
Trial record 1 of 1 for:    INCB 18424-258
Previous Study | Return to List | Next Study

Ruxolitinib (INCB018424) in Subjects With Primary Myelofibrosis, Post Essential Thrombocythemia-myelofibrosis and Post Polycythemia Vera-myelofibrosis

This study is currently recruiting participants. (see Contacts and Locations)
Verified September 2016 by Incyte Corporation
Information provided by (Responsible Party):
Incyte Corporation Identifier:
First received: May 4, 2011
Last updated: September 23, 2016
Last verified: September 2016
No Study Results Posted on for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: September 2020
  Estimated Primary Completion Date: February 2018 (Final data collection date for primary outcome measure)
Publications automatically indexed to this study by Identifier (NCT Number):